Mon, February 6, 2023

Jonathan Wolleben Reiterated (ALT) at Buy and Held Target at $26 on, Feb 6th, 2023

Jonathan Wolleben of JMP Securities, Reiterated "Altimmune, Inc." (ALT) at Buy and Held Target at $26 on, Feb 6th, 2023.

Jonathan has made no other calls on ALT in the last 4 months.



There are 3 other peers that have a rating on ALT. Out of the 3 peers that are also analyzing ALT, 0 agree with Jonathan's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Jonathan


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $50 on, Friday, January 20th, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Increased Target to $25 on, Wednesday, January 18th, 2023
  • Corinne Jenkins of "Goldman Sachs" Initiated at Strong Buy and Held Target at $20 on, Thursday, December 1st, 2022